TreeWAS – Variant ID: rs746961

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.000	0.915	0.085
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.916	0.084
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.919	0.081
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract	0.000	0.924	0.076
T83.3 Mechanical complication of intra-uterine contraceptive device	0.000	0.926	0.074
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.000	0.929	0.071
T83.9 Unspecified complication of genito-urinary prosthetic device, implant and graft	0.000	0.932	0.068
T83.0 Mechanical complication of urinary (indwelling) catheter	0.000	0.937	0.063
T83.2 Mechanical complication of graft of urinary organ	0.000	0.944	0.056
T83.1 Mechanical complication of other urinary devices and implants	0.000	0.974	0.026
M10.99 Gout, unspecified (Site unspecified)	0.017	0.983	0.000
M10.94 Gout, unspecified (Hand)	0.014	0.986	0.000
M10.9 Gout, unspecified	0.014	0.986	0.000
Y85.0 Sequelae of motor-vehicle accident	0.000	0.986	0.014
M10.90 Gout, unspecified (Multiple sites)	0.011	0.989	0.000
M10.92 Gout, unspecified (Upper arm)	0.011	0.989	0.000
M10.98 Gout, unspecified (Other)	0.010	0.989	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.010	0.989	0.000
M10.91 Gout, unspecified (Shoulder region)	0.010	0.989	0.000
M10.96 Gout, unspecified (Lower leg)	0.010	0.990	0.000
M10.93 Gout, unspecified (Forearm)	0.010	0.990	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.992	0.008
M10 Gout	0.008	0.992	0.000
H16.0 Corneal ulcer	0.008	0.992	0.000
I49.5 Sick sinus syndrome	0.000	0.993	0.007
M10.97 Gout, unspecified (Ankle and foot)	0.007	0.993	0.000
Y85 Sequelae of transport accidents	0.000	0.993	0.007
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.993	0.007
M10.0 Idiopathic gout	0.007	0.993	0.000
K14.9 Disease of tongue, unspecified	0.000	0.994	0.006
M10.04 Idiopathic gout (Hand)	0.006	0.994	0.000
M10.4 Other secondary gout	0.006	0.994	0.000
M10.2 Drug-induced gout	0.006	0.994	0.000
M10.1 Lead-induced gout	0.006	0.994	0.000
M10.3 Gout due to impairment of renal function	0.006	0.994	0.000
M10.09 Idiopathic gout (Site unspecified)	0.005	0.994	0.000
J02.9 Acute pharyngitis, unspecified	0.000	0.995	0.005
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.995	0.005
C84.5 Other and unspecified T-cell lymphomas	0.005	0.995	0.000
M10.08 Idiopathic gout (Other)	0.005	0.995	0.000
M10.06 Idiopathic gout (Lower leg)	0.005	0.995	0.000
M10.05 Idiopathic gout (Pelvic region and thigh)	0.005	0.995	0.000
M10.03 Idiopathic gout (Forearm)	0.005	0.995	0.000
M10.02 Idiopathic gout (Upper arm)	0.005	0.995	0.000
M10.01 Idiopathic gout (Shoulder region)	0.005	0.995	0.000
M10.00 Idiopathic gout (Multiple sites)	0.005	0.995	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.005	0.995	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.005	0.995	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.005	0.995	0.000
C92.0 Acute myeloid leukaemia	0.005	0.995	0.000
C84.4 Peripheral T-cell lymphoma	0.005	0.995	0.000
H16 Keratitis	0.005	0.995	0.000
M10.19 Lead-induced gout (Site unspecified)	0.004	0.995	0.000
M10.18 Lead-induced gout (Other)	0.004	0.995	0.000
M10.17 Lead-induced gout (Ankle and foot)	0.004	0.995	0.000
M10.16 Lead-induced gout (Lower leg)	0.004	0.995	0.000
M10.15 Lead-induced gout (Pelvic region and thigh)	0.004	0.995	0.000
M10.14 Lead-induced gout (Hand)	0.004	0.995	0.000
M10.13 Lead-induced gout (Forearm)	0.004	0.995	0.000
M10.12 Lead-induced gout (Upper arm)	0.004	0.995	0.000
M10.11 Lead-induced gout (Shoulder region)	0.004	0.995	0.000
M10.10 Lead-induced gout (Multiple sites)	0.004	0.995	0.000
M10.29 Drug-induced gout (Site unspecified)	0.004	0.995	0.000
M10.28 Drug-induced gout (Other)	0.004	0.995	0.000
M10.27 Drug-induced gout (Ankle and foot)	0.004	0.995	0.000
M10.26 Drug-induced gout (Lower leg)	0.004	0.995	0.000
M10.25 Drug-induced gout (Pelvic region and thigh)	0.004	0.995	0.000
M10.24 Drug-induced gout (Hand)	0.004	0.995	0.000
M10.23 Drug-induced gout (Forearm)	0.004	0.995	0.000
M10.22 Drug-induced gout (Upper arm)	0.004	0.995	0.000
M10.21 Drug-induced gout (Shoulder region)	0.004	0.995	0.000
M10.20 Drug-induced gout (Multiple sites)	0.004	0.995	0.000
M10.49 Other secondary gout (Site unspecified)	0.004	0.995	0.000
M10.48 Other secondary gout (Other)	0.004	0.995	0.000
M10.47 Other secondary gout (Ankle and foot)	0.004	0.995	0.000
M10.46 Other secondary gout (Lower leg)	0.004	0.995	0.000
M10.45 Other secondary gout (Pelvic region and thigh)	0.004	0.995	0.000
M10.44 Other secondary gout (Hand)	0.004	0.995	0.000
M10.43 Other secondary gout (Forearm)	0.004	0.995	0.000
M10.42 Other secondary gout (Upper arm)	0.004	0.995	0.000
M10.41 Other secondary gout (Shoulder region)	0.004	0.995	0.000
M10.40 Other secondary gout (Multiple sites)	0.004	0.995	0.000
C80.9 Malignant neoplasm, unspecified	0.004	0.996	0.000
M10.38 Gout due to impairment of renal function (Other)	0.004	0.996	0.000
M10.37 Gout due to impairment of renal function (Ankle and foot)	0.004	0.996	0.000
M10.36 Gout due to impairment of renal function (Lower leg)	0.004	0.996	0.000
M10.35 Gout due to impairment of renal function (Pelvic region and thigh)	0.004	0.996	0.000
M10.34 Gout due to impairment of renal function (Hand)	0.004	0.996	0.000
M10.33 Gout due to impairment of renal function (Forearm)	0.004	0.996	0.000
M10.32 Gout due to impairment of renal function (Upper arm)	0.004	0.996	0.000
M10.31 Gout due to impairment of renal function (Shoulder region)	0.004	0.996	0.000
M10.30 Gout due to impairment of renal function (Multiple sites)	0.004	0.996	0.000
C92 Myeloid leukaemia	0.004	0.996	0.000
I49.8 Other specified cardiac arrhythmias	0.000	0.996	0.004
F43.2 Adjustment disorders	0.000	0.996	0.004
C82.4 Follicular lymphoma grade IIIb	0.004	0.996	0.000
M10.39 Gout due to impairment of renal function (Site unspecified)	0.004	0.996	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
M10.07 Idiopathic gout (Ankle and foot)	0.004	0.996	0.000
C82.3 Follicular lymphoma grade IIIa	0.004	0.996	0.000
C88 Malignant immunoproliferative diseases	0.004	0.996	0.000
C82.0 Small cleaved cell, follicular	0.004	0.996	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.004	0.996	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.004	0.996	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.004	0.996	0.000
C92.9 Myeloid leukaemia, unspecified	0.004	0.996	0.000
H16.4 Corneal neovascularisation	0.004	0.996	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.004	0.996	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.004	0.996	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.004	0.996	0.000
C84.3 Lymphoepithelioid lymphoma	0.004	0.996	0.000
C84.2 T-zone lymphoma	0.004	0.996	0.000
C84.1 Sezary's diease	0.004	0.996	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.004	0.996	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.004	0.996	0.000
C82.6 Cutaneous follicle centre lymphoma	0.004	0.996	0.000
C82.5 Diffuse follicle centre lymphoma	0.004	0.996	0.000
K09.0 Developmental odontogenic cysts	0.004	0.996	0.000
H16.8 Other keratitis	0.004	0.996	0.000
C95 Leukaemia of unspecified cell type	0.004	0.996	0.000
M24.26 Disorder of ligament (Lower leg)	0.000	0.996	0.004
H16.9 Keratitis, unspecified	0.003	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.996	0.003
C94 Other leukaemias of specified cell type	0.003	0.996	0.000
C86 Other specified types of T/NK-cell lymphoma	0.003	0.996	0.000
C95.9 Leukaemia, unspecified	0.003	0.996	0.000
C84.0 Mycosis fungoides	0.003	0.997	0.000
H16.3 Interstitial and deep keratitis	0.003	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.003	0.997	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.003	0.997	0.000
C92.3 Myeloid sarcoma	0.003	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.003	0.997	0.000
C92.5 Acute myelomonocytic leukaemia	0.003	0.997	0.000
N92.5 Other specified irregular menstruation	0.000	0.997	0.003
C82.2 Large cell, follicular	0.003	0.997	0.000
C92.4 Acute promyelocytic leukaemia	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
C81.1 Nodular sclerosis	0.003	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
H16.2 Keratoconjunctivitis	0.003	0.997	0.000
T50.8 Diagnostic agents	0.000	0.997	0.003
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
C81 Hodgkin's disease	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
C93 Monocytic leukaemia	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
L40.0 Psoriasis vulgaris	0.003	0.997	0.000
J02 Acute pharyngitis	0.000	0.997	0.003
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.003	0.997	0.000
T86.1 Kidney transplant failure and rejection	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
C91.0 Acute lymphoblastic leukaemia	0.003	0.997	0.000
C92.7 Other myeloid leukaemia	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
M89.86 Other specified disorders of bone (Lower leg)	0.003	0.997	0.000
C94.7 Other specified leukaemias	0.003	0.997	0.000
C94.5 Acute myelofibrosis	0.003	0.997	0.000
C94.4 Acute panmyelosis	0.003	0.997	0.000
C94.3 Mast cell leukaemia	0.003	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.003	0.997	0.000
C94.1 Chronic erythraemia	0.003	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.003	0.997	0.000
J02.0 Streptococcal pharyngitis	0.000	0.997	0.003
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
I51.8 Other ill-defined heart diseases	0.000	0.997	0.003
Z34.8 Supervision of other normal pregnancy	0.000	0.997	0.003
C91.4 Hairy-cell leukaemia	0.003	0.997	0.000
C81.7 Other Hodgkin's disease	0.002	0.997	0.000
C91.5 Adult T-cell leukaemia	0.003	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.997	0.000
C96.8 Histiocytic sarcoma	0.002	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.997	0.000
C96.3 True histiocytic lymphoma	0.002	0.997	0.000
C96.2 Malignant mast cell tumour	0.002	0.997	0.000
C96.1 Malignant histiocytosis	0.002	0.997	0.000
C96.0 Letterer-Siwe disease	0.002	0.997	0.000
I35.9 Aortic valve disorder, unspecified	0.000	0.997	0.003
J02.8 Acute pharyngitis due to other specified organisms	0.000	0.997	0.003
I49 Other cardiac arrhythmias	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
C71.8 Overlapping lesion of brain	0.003	0.997	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.003	0.997	0.000
F43.1 Posttraumatic stress disorder	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.002
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.002	0.997	0.000
C81.3 Lymphocytic depletion	0.002	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.002	0.997	0.000
C91.7 Other lymphoid leukaemia	0.002	0.997	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.002	0.997	0.000
C91.3 Prolymphocytic leukaemia	0.002	0.997	0.000
C91.2 Subacute lymphocytic leukaemia	0.002	0.997	0.000
H50.0 Convergent concomitant strabismus	0.000	0.997	0.003
C93.9 Monocytic leukaemia, unspecified	0.002	0.997	0.000
C93.7 Other monocytic leukaemia	0.002	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.997	0.000
C93.0 Acute monocytic leukaemia	0.002	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.002
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.998	0.002
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
M25.86 Other specified joint disorders (Lower leg)	0.000	0.998	0.002
C80 Malignant neoplasm without specification of site	0.002	0.998	0.000
S50.9 Superficial injury of forearm, unspecified	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.998	0.000
C81.2 Mixed cellularity	0.002	0.998	0.001
M25.84 Other specified joint disorders (Hand)	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
U80.0 Penicillin resistant agent	0.000	0.998	0.002
R45.8 Other symptoms and signs involving emotional state	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
C91.9 Lymphoid leukaemia, unspecified	0.002	0.998	0.000
T40.5 Cocaine	0.000	0.998	0.002
M25.87 Other specified joint disorders (Ankle and foot)	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
C81.0 Lymphocytic predominance	0.002	0.998	0.001
C80.0 Malignant neoplasm, primary site unknown, so stated	0.002	0.998	0.000
F43 Reaction to severe stress, and adjustment disorders	0.000	0.998	0.002
M43.17 Spondylolisthesis (Lumbosacral region)	0.002	0.998	0.000
M60.05 Infective myositis (Pelvic region and thigh)	0.002	0.998	0.000
I49.2 Junctional premature depolarisation	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
C71.2 Temporal lobe	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.000	0.998	0.002
D33.3 Cranial nerves	0.000	0.998	0.002
M25.8 Other specified joint disorders	0.000	0.998	0.002
T21.0 Burn of unspecified degree of trunk	0.002	0.998	0.000
D75.9 Disease of blood and blood-forming organs, unspecified	0.002	0.998	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.002	0.998	0.000
R94.4 Abnormal results of kidney function studies	0.002	0.998	0.000
T40.2 Other opioids	0.000	0.998	0.002
N93.8 Other specified abnormal uterine and vaginal bleeding	0.002	0.998	0.000
T21.1 Burn of first degree of trunk	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
I49.0 Ventricular fibrillation and flutter	0.000	0.998	0.002
M14 Arthropathies in other diseases classified elsewhere	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
C71.3 Parietal lobe	0.002	0.998	0.000
M14.2 Diabetic arthropathy	0.002	0.998	0.000
S43.0 Dislocation of shoulder joint	0.002	0.998	0.000
X62.9 Unspecified place	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
D75.2 Essential thrombocytosis	0.002	0.998	0.000
L40.9 Psoriasis, unspecified	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
I49.1 Atrial premature depolarisation	0.000	0.998	0.002
T86.0 Bone-marrow transplant rejection	0.002	0.998	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.000	0.998	0.002
D75 Other diseases of blood and blood-forming organs	0.002	0.998	0.000
M05 Seropositive rheumatoid arthritis	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
H93.1 Tinnitus	0.000	0.998	0.002
S20.2 Contusion of thorax	0.000	0.998	0.002
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
R94.3 Abnormal results of cardiovascular function studies	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.998	0.002
D75.8 Other specified diseases of blood and blood-forming organs	0.002	0.998	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.998	0.002
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
T21 Burn and corrosion of trunk	0.002	0.998	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.002	0.998	0.000
M14.8 Arthropathies in other specified diseases classified elsewhere	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.998	0.002
C81.9 Hodgkin's disease, unspecified	0.000	0.998	0.001
K55.9 Vascular disorder of intestine, unspecified	0.000	0.998	0.002
M60.0 Infective myositis	0.002	0.998	0.000
R47.1 Dysarthria and anarthria	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
F43.8 Other reactions to severe stress	0.000	0.998	0.002
H18.4 Corneal degeneration	0.002	0.998	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.998	0.002
M14.6 Neuropathic arthropathy	0.002	0.998	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
D23.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
M14.5 Arthropathies in other endocrine, nutritional and metabolic disorders	0.002	0.998	0.000
Z44.3 Fitting and adjustment of external breast prosthesis	0.000	0.998	0.002
L40 Psoriasis	0.002	0.998	0.000
T86 Failure and rejection of transplanted organs and tissues	0.002	0.998	0.000
D75.0 Familial erythrocytosis	0.002	0.998	0.000
H81.1 Benign paroxysmal vertigo	0.000	0.998	0.002
R94.0 Abnormal results of function studies of central nervous system	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
D75.1 Secondary polycythaemia	0.002	0.998	0.000
T21.3 Burn of third degree of trunk	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
M25.89 Other specified joint disorders (Site unspecified)	0.000	0.998	0.002
M25.80 Other specified joint disorders (Multiple sites)	0.000	0.998	0.002
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.002	0.998	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
M25.82 Other specified joint disorders (Upper arm)	0.000	0.998	0.002
D46.9 Myelodysplastic syndrome, unspecified	0.002	0.998	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
M14.4 Arthropathy in amyloidosis	0.002	0.998	0.000
M14.3 Lipoid dermatoarthritis	0.002	0.998	0.000
M14.1 Crystal arthropathy in other metabolic disorders	0.002	0.998	0.000
M14.0 Gouty arthropathy due to enzyme defects and other inherited disorders	0.002	0.998	0.000
R22.2 Localised swelling, mass and lump, trunk	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
M05.8 Other seropositive rheumatoid arthritis	0.002	0.998	0.000
M05.1 Rheumatoid lung disease	0.002	0.998	0.000
Q43.0 Meckel's diverticulum	0.002	0.998	0.000
R94.2 Abnormal results of pulmonary function studies	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
W22.9 Unspecified place	0.002	0.998	0.000
M05-M14 Inflammatory polyarthropathies	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
L40.4 Guttate psoriasis	0.002	0.998	0.000
S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee	0.000	0.998	0.002
U80 Agent resistant to penicillin and related antibiotics	0.000	0.998	0.002
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.002	0.998	0.000
M25.88 Other specified joint disorders (Other)	0.000	0.998	0.002
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.002	0.998	0.000
R94 Abnormal results of function studies	0.002	0.998	0.000
S52.80 Fracture of other parts of forearm (closed)	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.002	0.998	0.000
M60.08 Infective myositis (Other)	0.002	0.998	0.000
D33.0 Brain, supratentorial	0.000	0.998	0.002
G24.9 Dystonia, unspecified	0.002	0.998	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.002	0.998	0.000
M05.2 Rheumatoid vasculitis	0.002	0.998	0.000
M05.0 Felty's syndrome	0.002	0.998	0.000
T36.3 Macrolides	0.000	0.998	0.001
T49.9 Topical agent, unspecified	0.000	0.998	0.001
T49.8 Other topical agents	0.000	0.998	0.001
T49.7 Dental drugs, topically applied	0.000	0.998	0.001
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.001
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.001
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.001
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.001
T49.2 Local astringents and local detergents	0.000	0.998	0.001
T49.1 Antipruritics	0.000	0.998	0.001
D33.2 Brain, unspecified	0.000	0.998	0.002
I49.4 Other and unspecified premature depolarisation	0.000	0.998	0.002
C71.7 Brain stem	0.001	0.998	0.000
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
T21.2 Burn of second degree of trunk	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.000	0.998	0.002
C71.5 Cerebral ventricle	0.001	0.998	0.000
C83.0 Small cell (diffuse)	0.002	0.998	0.000
G00.9 Bacterial meningitis, unspecified	0.000	0.998	0.002
T21.7 Corrosion of third degree of trunk	0.001	0.998	0.000
T21.6 Corrosion of second degree of trunk	0.001	0.998	0.000
T21.5 Corrosion of first degree of trunk	0.001	0.998	0.000
T21.4 Corrosion of unspecified degree of trunk	0.001	0.998	0.000
M60.09 Infective myositis (Site unspecified)	0.001	0.998	0.000
M60.07 Infective myositis (Ankle and foot)	0.001	0.998	0.000
M60.06 Infective myositis (Lower leg)	0.001	0.998	0.000
M60.04 Infective myositis (Hand)	0.001	0.998	0.000
M60.03 Infective myositis (Forearm)	0.001	0.998	0.000
M60.02 Infective myositis (Upper arm)	0.001	0.998	0.000
M60.01 Infective myositis (Shoulder region)	0.001	0.998	0.000
M60.00 Infective myositis (Multiple sites)	0.001	0.998	0.000
M79.79 Fibromyalgia (Site unspecified)	0.002	0.998	0.000
B94.8 Sequelae of other specified infectious and parasitic diseases	0.002	0.998	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.002	0.998	0.000
R94.8 Abnormal results of function studies of other organs and systems	0.002	0.998	0.000
T45.5 Anticoagulants	0.000	0.998	0.002
T86.9 Failure and rejection of unspecified transplanted organ and tissue	0.001	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
L40.8 Other psoriasis	0.002	0.998	0.000
L40.3 Pustulosis palmaris et plantaris	0.001	0.998	0.000
L40.2 Acrodermatitis continua	0.001	0.998	0.000
Q51.8 Other congenital malformations of uterus and cervix	0.002	0.998	0.000
R94.1 Abnormal results of function studies of peripheral nervous system and special senses	0.001	0.998	0.000
I60.8 Other subarachnoid haemorrhage	0.002	0.998	0.000
T86.3 Heart-lung transplant failure and rejection	0.001	0.998	0.000
T86.2 Heart transplant failure and rejection	0.001	0.998	0.000
Z46.8 Fitting and adjustment of other specified devices	0.000	0.998	0.002
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.001	0.998	0.000
M25.83 Other specified joint disorders (Forearm)	0.000	0.998	0.001
M25.81 Other specified joint disorders (Shoulder region)	0.000	0.998	0.001
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.001
T86.8 Failure and rejection of other transplanted organs and tissues	0.002	0.998	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.001	0.998	0.000
M05.10 Rheumatoid lung disease (Multiple sites)	0.001	0.998	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.001	0.998	0.000
C90.3 Solitary plasmacytoma	0.001	0.998	0.000
M60.2 Foreign body granuloma of soft tissue, not elsewhere classified	0.001	0.998	0.000
S43.5 Sprain and strain of acromioclavicular joint	0.001	0.998	0.000
S49.9 Unspecified injury of shoulder and upper arm	0.002	0.998	0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
C83 Diffuse non-Hodgkin's lymphoma	0.001	0.998	0.000
M60.24 Foreign body granuloma of soft tissue, not elsewhere classified (Hand)	0.001	0.998	0.000
C71.9 Brain, unspecified	0.002	0.998	0.000
F43.9 Reaction to severe stress, unspecified	0.000	0.998	0.001
N30.8 Other cystitis	0.002	0.998	0.000
N48.6 Balanitis xerotica obliterans	0.000	0.998	0.002
D33 Benign neoplasm of brain and other parts of central nervous system	0.000	0.998	0.002
M60 Myositis	0.001	0.998	0.000
M05.18 Rheumatoid lung disease (Other)	0.001	0.998	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.001	0.998	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.001	0.998	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.001	0.998	0.000
M05.14 Rheumatoid lung disease (Hand)	0.001	0.998	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.001	0.998	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.001	0.998	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.001	0.998	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.001	0.998	0.000
M05.88 Other seropositive rheumatoid arthritis (Other)	0.001	0.998	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.001	0.998	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.001	0.998	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.001	0.998	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations